PAVmed Inc.
PAVM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $2,995 | $2,452 | $377 | $500 |
| % Growth | 22.1% | 550.4% | -24.6% | – |
| Cost of Goods Sold | $6,038 | $6,420 | $3,614 | $585 |
| Gross Profit | -$3,043 | -$3,968 | -$3,237 | -$85 |
| % Margin | -101.6% | -161.8% | -858.6% | -17% |
| R&D Expenses | $5,932 | $14,276 | $25,338 | $19,847 |
| G&A Expenses | $24,524 | $30,947 | $41,410 | $25,566 |
| SG&A Expenses | $36,151 | $48,530 | $60,728 | $34,461 |
| Sales & Mktg Exp. | $11,627 | $17,583 | $19,318 | $8,895 |
| Other Operating Expenses | -$639 | $2,021 | $1,784 | $0 |
| Operating Expenses | $41,444 | $64,827 | $87,850 | $54,308 |
| Operating Income | -$44,487 | -$68,795 | -$91,087 | -$54,393 |
| % Margin | -1,485.4% | -2,805.7% | -24,161% | -10,878.6% |
| Other Income/Exp. Net | $72,914 | -$10,468 | -$12,151 | -$1,733 |
| Pre-Tax Income | $28,427 | -$79,263 | -$103,238 | -$56,126 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $39,791 | -$64,175 | -$88,983 | -$50,347 |
| % Margin | 1,328.6% | -2,617.3% | -23,602.9% | -10,069.4% |
| EPS | 3.305 | -9.164 | -15.032 | -9.797 |
| % Growth | 136.1% | 39% | -53.4% | – |
| EPS Diluted | 0.496 | -9.164 | -15.032 | -9.797 |
| Weighted Avg Shares Out | 9,672 | 7,232 | 5,938 | 5,168 |
| Weighted Avg Shares Out Dil | 65,292 | 7,232 | 5,938 | 5,168 |
| Supplemental Information | – | – | – | – |
| Interest Income | $254 | $505 | $169 | $0 |
| Interest Expense | $45 | $589 | $1,281 | $0 |
| Depreciation & Amortization | $1,198 | $2,932 | $2,457 | $226 |
| EBITDA | $29,670 | -$75,742 | -$99,500 | -$55,900 |
| % Margin | 990.7% | -3,089% | -26,392.6% | -11,180% |